NCT01502202 2012-06-20
Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers
National Cancer Center, Korea
Phase 2 Unknown
National Cancer Center, Korea
National Cancer Center, Korea
Taipei Veterans General Hospital, Taiwan